SCHEMBL8993479

SCHEMBL8993479

O=C1NN[C@H](Cc2ccccc2)[C@@H]1c1cccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.40
MTNR1A P48039 2/20 0.38
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TDP2 O95551 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP3 P42574 1/20 0.34
HTT P42858 1/20 0.34
GALK1 P51570 1/20 0.34
BLM P54132 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8993508 0.76 IDO1 (0.46) IDO1MTNR1ACYP1A2CYP2D6CYP2C9
SCHEMBL8993465 0.76 IDO1 (0.46) IDO1MTNR1ACYP1A2CYP2D6CYP2C9
SCHEMBL5749862 0.64 MAOB (0.43) MAOBGSK3BADKPARP1
SCHEMBL8993638 0.62 GAA (0.37) IDO1MTNR1ACYP1A2ALDH1A1MAPT
SCHEMBL3644737 0.62 HDAC8 (0.33) MAOB
SCHEMBL6380847 0.61 IDO1 (0.54) IDO1MTNR1AALDH1A1MAPTHPGD
SCHEMBL17070912 0.60 EP300 (0.48) HTTMAOBGSK3B
SCHEMBL30062572 0.60 PLA2G10 (0.49) CYP1A2CYP2C19
SCHEMBL24017027 0.60 MTNR1A (0.49) IDO1MTNR1AALDH1A1MAPTHPGD
SCHEMBL31252704 0.59 SLC6A4 (0.44) IDO1MTNR1ACYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574169-A CHOLECYSTOKININ ANTAGONIST ELI LILLY AND COMPANY (US) 1996-11-12 US disclosed
US-5399708-A Cholecystokinin and gastrin antagonists; gastrointestinal and central nervous system disorders ELI LILLY AND COMPANY (US) 1995-03-21 US disclosed